GO2 for Lung Cancer

Diagnosed with lung cancer before age 50? You can help researchers understand why younger adults are getting this disease. Help us find answers! Learn more about this crucial study today.?? https://lnkd.in/eX75uexp

? Have you navigated a #LungCancer diagnosis? Your experience could be a lifeline for someone else. Through our ?????????? ?????????? ??????????????, we connect people facing lung cancer with survivors who understand—because they’ve been there, too. As a volunteer, you’ll provide support, share insight, and make a real difference in someone’s experience. ?? Ready to be there for someone who needs it? Learn more about becoming a Phone Buddy: https://lnkd.in/ebBTBxMX

???????? ???? ????????-???????????????? ???????? ????????????? ?? EGFR (epidermal growth factor receptor) is a gene that helps cells grow and survive. But when it mutates, it can lead to lung cancer, specifically EGFR-positive lung cancer, which accounts for about 15% of all lung cancer cases. Understanding your specific #EGFR mutation is key to developing the right treatment plan. That’s why we teamed up with WebMD for a 2-part podcast featuring experts and a survivor’s firsthand experience. ?? Listen now to get the facts. ?? https://lnkd.in/eJYc7Gzu

#Immunotherapy is changing the landscape of #LungCancer treatment! In our latest Lung Cancer Living Room?, Greg Allen, MD, PhD, from UCSF breaks down the latest advancements in immune checkpoint inhibitors (ICIs) and T-cell engagers (TCEs)—treatments helping the immune system recognize and fight lung cancer more effectively. ?? ?? Learn how #BiomarkerTesting plays a crucial role in determining the right treatment. ?? Discover the current immunotherapy options for #NSCLC and #SCLC. ?? Get expert insights and free resources to help navigate your lung cancer experience. ?? Watch the full discussion: https://lnkd.in/epBbFZwe

This week on #CapitolHill, #LungCancer advocates were hard at work championing #CancerResearchFunding, and along the way, we crossed paths with fellow advocates from the colorectal cancer community! While advocating separately, we were all united in asking Congress to fully fund the Congressionally Directed Medical Research Program (#CDMRP), because investment in cancer research saves lives. ???? #VoicesSummit

A heartfelt thank you to our sponsors, AstraZeneca and Merck, for their unwavering support of the 2025 #VoicesSummit. Your dedication to advancing #LungCancerAwareness, research, and treatment plays a vital role in driving progress for those affected by this disease. Together, we are making a lasting impact.

URGENT: Contact Senators to VOTE NO on the current proposed Continuing Resolution that cuts the DoD’s Congressionally Directed Medical Research Program (CDMRP), putting the Lung Cancer Research Program (LCRP) funding at risk for 2025. Without this funding, critical lung cancer research could come to a halt. Contact your Senator NOW to protect life-saving federal research funding: https://bit.ly/4buCtRg

?? Thirteen years ago, Debbie was told she had only 1-2 years to live after being diagnosed with stage 4 (IV) #LungCancer. But she didn’t let it stop her. She sought second opinions, underwent #BiomarkerTesting, and found a treatment that worked for her. Today, she’s not just surviving, she’s thriving. Read how she navigated her diagnosis, treatments, and life as a long-term survivor. ?? https://lnkd.in/e5Jse8mK

The landscape of small cell lung cancer (SCLC) treatment is evolving, with new research shaping the future of care. Join us for the next Lung Cancer Living Room? as Carl M. Gay, MD, PhD, Assistant Professor, Department of Thoracic-Head & Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses current treatment options, the role of #immunotherapy, and what’s on the horizon for #SCLC. ?? Join virtually on YouTube Live or in person at GO2’s San Carlos office ?? Bring your questions and be part of the conversation! ???????????????? ??????: https://lnkd.in/gQGraJup

That’s a wrap on the 2025 #VoicesSummit! ?? Over the past few days, advocates have made their voices heard, pushing for increased research funding, stronger policies, and better care for those impacted by #LungCancer. Our work doesn’t end here. Advocacy is year-round, and together, we’ll keep driving change! ??